Match!
Karen L. Rascati
University of Texas at Austin
PharmacyIntensive care medicinePhysical therapyFamily medicineMedicine
263Publications
24H-index
2,202Citations
What is this?
Publications 262
Newest
#1Karen L. Rascati (University of Texas at Austin)H-Index: 24
Source
#1Qais Alefan (JUST: Jordan University of Science and Technology)H-Index: 4
#2Esra’a Hamdouni (JUST: Jordan University of Science and Technology)
Last. Karen L. Rascati (University of Texas at Austin)H-Index: 24
view all 5 authors...
: Background: Pharmacoeconomics estimates the value of pharmaceutical products and services and provides healthcare decision-makers with valuable information. Pharmacoeconomic evaluations have not been found to be influential in the Jordanian health care system. Although pharmacoeconomics as a concept is becoming more recognized in the pharmaceutical world, there are still some barriers to its implementation.Objective: To establish the perceived barriers to the implementation of pharmacoeconomic...
Source
#2Karen L. RascatiH-Index: 24
Last. James P. WilsonH-Index: 17
view all 4 authors...
Source
#2Jamie C. BarnerH-Index: 25
Last. Karen L. RascatiH-Index: 24
view all 4 authors...
Source
#2Kenneth A. LawsonH-Index: 24
Last. Kristin M. RichardsH-Index: 7
view all 5 authors...
Source
#2Jamie C. BarnerH-Index: 25
Last. Karen L. RascatiH-Index: 24
view all 4 authors...
Source
#2Karen L. RascatiH-Index: 24
Last. Kristin M. RichardsH-Index: 7
view all 4 authors...
Source
#1Elmor D. Pineda (University of Texas at Austin)
#2I-Chia Liao (Scott & White Hospital)
Last. Karen L. Rascati (University of Texas at Austin)H-Index: 24
view all 5 authors...
BACKGROUND: Cardiovascular disease (CVD) remains the most prevalent cause of morbidity and mortality in patients with type 2 diabetes (T2D) and is a primary driver for health care costs associated with diabetes management. Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated significant reductions in cardiovascular endpoints in clinical trials compared with placebo. However, it is uncertain whether these findings can be ...
Source
#1Qais Alefan (JUST: Jordan University of Science and Technology)H-Index: 4
#2S. Al-Emam (JUST: Jordan University of Science and Technology)H-Index: 1
Last. Karen L. Rascati (University of Texas at Austin)H-Index: 24
view all 6 authors...
Source
#1Somraj Ghosh (University of Texas at Austin)
#2Karen L. Rascati (University of Texas at Austin)H-Index: 24
view all 4 authors...
BACKGROUND: Analysis of salary data for health economics, outcomes research, and market access professionals in biopharmaceutical space plays an important role in hiring talent, benchmarking remune...
Source
12345678910